Krystal Biotech, Inc. (KRYS)
After hours:
| Previous Close | 161.76 |
| Open | 160.07 |
| Bid | 156.79 x 100 |
| Ask | 157.83 x 100 |
| Day's Range | 155.02 - 162.89 |
| 52 Week Range | 86.03 - 189.97 |
| Volume | |
| Avg. Volume | 398,626 |
| Market Cap | 4.503B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 72.33 |
| EPS (TTM) | 2.18 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 189.00 |
GlobeNewswireKrystal Biotech to Present at BofA Securities 2024 Health Care Conference
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the BofA Securities 2024 Health Care Conference on May 14, 2024, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 2:20 pm PT and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at
Insider MonkeyKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript May 6, 2024 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $0.03182 EPS, expectations were $0.2. Krystal Biotech, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […]
- GuruFocus.com
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
Discover how Krystal Biotech Inc (KRYS) sustains impressive revenue growth and navigates challenges in Q1 2024.
